Profil
Jens Bjørheim currently works at Zelluna ASA, as Chief Medical Officer.
Dr. Bjørheim also formerly worked at Pronova BioPharma ASA, as Medical Director from 2006 to 2008, AstraZeneca A, as Senior Medical Director-Oncology from 2013 to 2016, and Ultimovacs ASA, as Chief Medical Officer.
Dr. Bjørheim received his doctorate degree in 1999 from the University of Oslo and doctorate degree in 2003 from the University of Oslo.
Postes actifs de Jens Bjørheim
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Jens Bjørheim
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca A/S (Denmark)
AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Corporate Officer/Principal | 01/01/2016 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Directeur Technique/Scientifique/R&D | 01/01/2008 |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Directeur Technique/Scientifique/R&D | - |
Formation de Jens Bjørheim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca A/S (Denmark)
AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Health Technology |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
















